Erasmus MC

Kutatók

• BKBas Groot Koerkamp

Futó vizsgálatok

• Még nem toboroz

  A Phase 2 Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma

  NCT05494697· 2. fázis· Aim Immunotech Inc.· Forrás

• Még nem toboroz

  An open-label phase 1 dose-escalation study to evaluate safety, tolerability, pharmacokinetics, and exploratory assessments of PACAB-002 in patients with ovarian cancer with peritoneal spread

  2026-527184-15-00· 1. fázis· Nadeno Nanoscience AS· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure

  NCT07584967· 2. fázis· AnaCardio AB· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Toboroz

  ALBUMINUS: Dose reduction of human albumin during large-volume paracentesis in patients with cirrhosis

  2026-526167-38-00· 4. fázis· Amsterdam UMC Stichting· Forrás

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Még nem toboroz

  Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets

  NCT07234877· 2. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Toboroz

  SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY Trial

  NCT07872020· Erasmus Medical Center· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).

  2026-526139-20-00· 3. fázis· Kardigan Inc.· Forrás

• Még nem toboroz

  Hepatic arterial infusion versus intravenous oxaliplatin in a safety, feasibility, and pharmacokinetic study of liver-dominant malignancies – ARTEMIS OXYS-I trial

  2026-527509-39-01· 1/2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Még nem toboroz

  A Phase I Study using Oncolytic AdenoVirus Immunotherapy with Repeat Administrations in Recurrent GliOblastoma (VIRAGO)

  2025-524555-31-00· 1. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Még nem toboroz

  Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial

  2025-524593-42-00· 4. fázis· Universiteit Leiden· Forrás

• Még nem toboroz

  LEAF‑HCM: What can we learn from the early use of aficamten in people who have no symptoms but do have a thickened heart muscle with blood flow obstruction?

  2025-523090-42-00· 2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational Study

  NCT07924371· Hospital Universitari Vall d'Hebron Research Institute· Forrás

• Toboroz

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· 1. fázis· Charm Therapeutics· Forrás

• Toboroz

  ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment

  2025-523307-29-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)

  2026-525489-23-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· 3. fázis· Incyte Corporation· Forrás

• Még nem toboroz

  Pompe disease; new Outcomes measures, Treatment Effect and Novel Targeted Investigations for Advancing Long-term follow-up (POTENTIAL).

  2024-520365-31-01· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Még nem toboroz

  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

  NCT07630714· 2. fázis· AstraZeneca· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· 3. fázis· Kardigan, Inc.· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· AstraZeneca· Forrás

• Toboroz

  The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study

  NCT07529418· Institute of Cancer Research, United Kingdom· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

  2025-524336-19-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  Tarlatamab for SCLC Brain Metastases

  NCT07402343· 2. fázis· Maastricht University Medical Center· Forrás

• Toboroz

  A Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas

  NCT05685173· 1. fázis· Regeneron Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  Giving Upfront Anti-p40 to Reduce toxicity from Dual Immune Checkpoint Inhibition in Mesothelioma

  2026-526036-38-00· 2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors

  NCT07802678· 4. fázis· Sint Maartenskliniek· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)

  NCT07702760· Jasper Brugts MD PhD· Forrás

• Még nem toboroz

  A more sustainable perioperative treatment regimen for gastroesophageal cancer —replacing 5-FU with capecitabine within the FLOT regimen

  2026-526209-13-00· 1. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Még nem toboroz

  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  2026-525513-31-00· 3. fázis· Norges Teknisk-Naturvitenskapelige Universitet NTNU· Forrás

• Fut, nem toboroz

  Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase II study

  NCT06003998· 2. fázis· Catharina Ziekenhuis Stichting· Forrás

• Toboroz

  PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  2025-522883-34-00· 4. fázis· Universitair Medisch Centrum Groningen· Forrás

• Meghívásos bevonás

  Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

  NCT07108244· University Hospital, Basel, Switzerland· Forrás

• Toboroz

  European Study of the BrioVAD Heart Pump for Advanced Heart Failure

  NCT07252531· BrioHealth BV· Forrás

• Még nem toboroz

  PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer

  2025-523134-28-00· 2/3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  Boosting Osimertinib Blood Brain Barrier Penetration

  NCT07485452· 2. fázis· Maastricht University Medical Center· Forrás

• Még nem toboroz

  A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

  2024-516570-30-00· 2. fázis· Centre Hospitalier De Versailles· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

  NCT07570173· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

Showing 50 of 497.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák22 toboroz
• Vastagbélrák19 toboroz
• Máj- és epeúti rák16 toboroz
• Gyomor- és nyelőcsőrák15 toboroz
• Gyermekkori daganatok13 toboroz
• Hólyagrák13 toboroz
• Melanóma13 toboroz
• Hasnyálmirigyrák12 toboroz
• Mielóma multiplex12 toboroz
• Glioblasztóma11 toboroz
• Prosztatarák10 toboroz
• Szívelégtelenség10 toboroz
• Petefészekrák9 toboroz
• Crohn-betegség8 toboroz
• Pompe-betegség8 toboroz
• Fej-nyaki daganatok7 toboroz
• Zsírmáj (MASLD/MASH)7 toboroz
• Akut mieloid leukémia (AML)6 toboroz
• Dilated cardiomyopathy6 toboroz
• Méhtestrák6 toboroz
• Amiloidózis5 toboroz
• HIV-fertőzés5 toboroz
• Idiopátiás tüdőfibrózis5 toboroz
• Liver cirrhosis5 toboroz
• Magas vérnyomás5 toboroz
• Méhnyakrák5 toboroz
• Rheumatoid arthritis5 toboroz
• Aortic stenosis4 toboroz
• Mezotelióma4 toboroz
• Neuroendokrin daganatok4 toboroz
• Vesedaganat4 toboroz
• Akut limfoid leukémia (ALL)3 toboroz
• Alopecia areata3 toboroz
• Arthritis psoriatica3 toboroz
• Cisztás fibrózis3 toboroz
• Hipertrófiás kardiomiopátia3 toboroz
• Hodgkin-limfóma3 toboroz
• Koszorúér-betegség3 toboroz
• Krónikus vesebetegség3 toboroz
• Lupus (SLE)3 toboroz
• Sarcoidosis3 toboroz
• Stroke (szélütés)3 toboroz
• Aortic aneurysm2 toboroz
• Áttétes emlőrák2 toboroz
• Bronchiectasis2 toboroz
• Cushing's syndrome2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Familiáris hiperkoleszterinémia2 toboroz
• Follikuláris limfóma2 toboroz
• Hidradenitis suppurativa2 toboroz
• Immune thrombocytopenia (ITP)2 toboroz
• Köpenysejtes limfóma2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Krónikus limfoid leukémia (CLL)2 toboroz
• Migrén2 toboroz
• Pajzsmirigyrák2 toboroz
• Policisztás vesebetegség2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Sjögren-szindróma2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Tripla negatív emlőrák2 toboroz
• Vitiligo2 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Asztma1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Autizmus spektrumzavar1 toboroz
• Cerebral palsy1 toboroz
• Colitis ulcerosa1 toboroz
• Csontritkulás1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Elhízás1 toboroz
• Epilepszia1 toboroz
• Frontotemporális demencia1 toboroz
• Graves' disease and hyperthyroidism1 toboroz
• Hearing loss1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hypothyroidism1 toboroz
• Meningioma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuromyelitis optica (NMOSD)1 toboroz
• Pikkelysömör1 toboroz
• Pitvarfibrilláció1 toboroz
• Polycystic ovary syndrome1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Szarkóma1 toboroz

Lezárt vizsgálatok

• Lezárult

  A trial to learn how safe AZD9750 is and how well it works in people with metastatic prostate cancer when given with or without other anticancer drugs

  2024-516976-14-00· 1/2. fázis· AstraZeneca AB· Forrás

• Fut, nem toboroz

  Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  NCT07161037· 2. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  lmlifidase treatment tor acute inflammation in AQP4-lgG associated neuromyelitis optica spectrum disorder

  2024-517176-38-00· 2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· 2. fázis· CSL Behring· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

  NCT07037771· 3. fázis· Arrowhead Pharmaceuticals· Forrás

• Lezárult

  A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)

  NCT06684847· 3. fázis· Argenx· Forrás

• Toboroz

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  NCT06989112· 3. fázis· AstraZeneca· Forrás

• Lezárult

  The rimegePant in RElation to obeSiTy in mIGrainE study

  2024-513359-34-00· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

  NCT06593522· 2. fázis· Amgen· Forrás

• Lezárult

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

  NCT06637423· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

  NCT06685835· 2. fázis· Insmed Incorporated· Forrás

• Lezárult

  Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001

  NCT06705192· 1. fázis· Mads Kjolby· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  NCT06614192· 2. fázis· AbbVie· Forrás

• Lezárult

  THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)

  2024-516260-29-00· 3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Lezárult

  Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point of view. Tailoring of treatment is done by taking the presence of autoantibodies and the quick response to glucocorticoids and JAK inhibitors into account.

  2024-511530-12-01· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Lezárult

  Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF)

  NCT06317285· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Toboroz

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  NCT06274801· 3. fázis· Gossamer Bio USA, Inc.· Forrás

• Toboroz

  Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

  NCT06467357· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Optimizing reversal of HIV latency with combination therapy (pyrimethamine, lenalidomide, panobinostat)

  NCT06240520· 2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Lezárult

  A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma

  NCT06561425· 1/2. fázis· Lakefront Biotherapeutics· Forrás

• Leállították

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

  NCT06444451· 2. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Lezárult

  A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

  NCT06309992· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

  NCT06427122· Tamar Nijsten· Forrás

• Lezárult

  A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

  NCT06131398· 1. fázis· Amgen· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

  NCT06241118· 3. fázis· Sanofi· Forrás

• Toboroz

  A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.

  NCT06230224· 3. fázis· Regeneron Pharmaceuticals Inc.· Forrás

• Lezárult

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· 2. fázis· Sanofi· Forrás

• Visszavonták

  INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701

  NCT05703555· 2. fázis· Erasmus Medical Center· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06212999· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin

  NCT05977738· Korai 1. fázis· C.Dirven· Forrás

• Meghívásos bevonás

  Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

  NCT06191315· 3. fázis· Sanofi· Forrás

• Lezárult

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· 3. fázis· GB002, Inc.· Forrás

• Fut, nem toboroz

  A study to investigate the efficacy and safety of tezepelumab compared with placebo in children 5 to < 12 years old with severe asthma

  2022-502984-39-00· 3. fázis· AstraZeneca AB· Forrás

• Lezárult

  STRIDER: A phase II Study evaluaTing intRacranial effIcacy of JDQ443 in patiEnts with KRAS G12C+ NSCLC and bRain metastases

  2023-505721-13-00· 2. fázis· University Hospital Maastricht· Forrás

• Lezárult

  A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

  NCT05784246· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A phase I/II open label, multicenter study evaluating the feasibility, safety and efficacy of point-of-care manufactured antiBCMA CAR T cells (GLPG5301; BCMACP03) in subjects with relapsed/refractory Multiple Myeloma (RRMM)

  2022-500782-27-00· 1/2. fázis· Lakefront Biotherapeutics· Forrás

• Toboroz

  A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  NCT06095089· 1. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

  2023-505558-16-00· 3. fázis· Almirall S.A.· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· 3. fázis· LEO Pharma· Forrás

• Lezárult

  DUPI REDUCE trial (DUPIlumab dose REDUCtion in patients with controlled atopic Eczema): a multicenter, low-intervention, non-inferiority randomized controlled trial, embedded in the TREAT NL registry.

  2023-504171-24-00· 4. fázis· Amsterdam UMC· Forrás

• Lezárult

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

  NCT05952869· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age

  NCT05882357· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

  NCT05845814· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa

  NCT05849922· 2. fázis· Sanofi· Forrás

Showing 50 of 173.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Stroke (szélütés)195 munka · 7 vizsgálat
• Szívelégtelenség189 munka · 24 vizsgálat
• Elhízás152 munka · 6 vizsgálat
• Tüdőrák114 munka · 66 vizsgálat
• Prosztatarák114 munka · 25 vizsgálat
• Osteoarthritis108 munka · 0 vizsgálat
• Máj- és epeúti rák99 munka · 22 vizsgálat
• Pitvarfibrilláció87 munka · 7 vizsgálat
• Asztma68 munka · 3 vizsgálat
• Vastagbélrák65 munka · 29 vizsgálat
• Krónikus vesebetegség65 munka · 9 vizsgálat
• 2-es típusú cukorbetegség64 munka · 2 vizsgálat
• Koszorúér-betegség63 munka · 10 vizsgálat
• Gyomor- és nyelőcsőrák58 munka · 25 vizsgálat
• Melanóma52 munka · 22 vizsgálat
• Rheumatoid arthritis48 munka · 8 vizsgálat
• Méhnyakrák39 munka · 11 vizsgálat
• Hipertrófiás kardiomiopátia37 munka · 8 vizsgálat
• Hasnyálmirigyrák37 munka · 21 vizsgálat
• Skizofrénia37 munka · 0 vizsgálat
• Akut mieloid leukémia (AML)35 munka · 14 vizsgálat
• Migrén35 munka · 3 vizsgálat
• Hólyagrák34 munka · 23 vizsgálat
• Crohn-betegség33 munka · 11 vizsgálat
• Congenital heart disease33 munka · 1 vizsgálat
• Frontotemporális demencia33 munka · 5 vizsgálat
• Idiopátiás tüdőfibrózis30 munka · 16 vizsgálat
• Hidradenitis suppurativa29 munka · 15 vizsgálat
• Neuroendokrin daganatok28 munka · 9 vizsgálat
• Glioblasztóma27 munka · 17 vizsgálat